Literature DB >> 7812557

Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure.

H Becker1, U Brandenburg, J H Peter, P Von Wichert.   

Abstract

Sinus arrest and atrioventricular (AV) block have been demonstrated in as much as 30% of patients with sleep apnea (SA). The reversal of heart block after tracheostomy has been shown. Nasal continuous positive airway pressure (nCPAP) now is widely used as the treatment of SA, but little data are available on the effect of nCPAP on heart block in patients with SA. During a 17-mo period 239 patients were found to have SA in an ambulatory study. Heart block was identified in 17 (16 male, one female) of these patients. Standard polysomnography and two-channel long-term ECG before and during nCPAP therapy were performed in order to assess the effect of nCPAP on SA and heart block. Mean age of the 17 patients was 50.7 yr (range, 27 to 78 yr), mean respiratory disturbance index (RDI) was 90/h (SD +/- 36.1) before nCPAP and 6/h (SD +/- 6.2) on the second treatment night. The number of episodes of heart block during sleep decreased significantly (p < 0.001) from 1,575 before therapy to 165 during nCPAP. In 12 patients (70.6%) heart block was totally prevented by nCPAP. In another three patients, there was a 71 to 97% reduction in the number of episodes of heart block on the second treatment night, and in two of them a complete reversal occurred thereafter. Two patients exhibited an increase in block frequency during nCPAP, which was reversed after 4 wk of nCPAP in one but persisted in the other.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7812557     DOI: 10.1164/ajrccm.151.1.7812557

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

Review 1.  Heart block in patients with sleep apnoea.

Authors:  H F Becker; U Koehler; A Stammnitz; J H Peter
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification.

Authors:  V Sarramegna; F Talmont; P Demange; A Milon
Journal:  Cell Mol Life Sci       Date:  2003-08       Impact factor: 9.261

3.  Multiple heart pauses during sleep in a patient with obstructive sleep apnoea syndrome.

Authors:  Athanasia Pataka; Euphemia Daskalopoulou; Stefanos Papastefanou; Chousein Baltatzi; Petros Aggelopulos; Emmanuel Vlachogiannis
Journal:  Sleep Breath       Date:  2012-01-24       Impact factor: 2.816

4.  A heavy snorer with multiple prolonged asystoles during the night-reversal by CPAP therapy.

Authors:  Dalia Mataciuniene; Raminta Masaitiene; Ruta Mameniskiene; Valmantas Budrys
Journal:  Sleep Breath       Date:  2012-04-04       Impact factor: 2.816

5.  Treatment of tachycardia: bradycardia syndrome in a patient with obstructive sleep apnoea.

Authors:  Jakub Lagan; Palaniappan Saravanan
Journal:  BMJ Case Rep       Date:  2015-04-01

6.  [What is possible in outpatient care -- what is needed for inpatient care?].

Authors:  Fokko de Haan
Journal:  Herz       Date:  2008-09       Impact factor: 1.443

7.  Metabolic syndrome and sleep apnea.

Authors:  I Kostoglou-Athanassiou; P Athanassiou
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

Review 8.  Effect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Younghoon Kwon; Ryan J Koene; Osung Kwon; Jessica V Kealhofer; Selcuk Adabag; Sue Duval
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-02

Review 9.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

10.  Obstructive sleep apnea and cardiac arrhythmias.

Authors:  Ahmad Salah Hersi
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.